Azepanone-based inhibitors of human cathepsin S: optimization of selectivity via the P2 substituent.
Bioorg Med Chem Lett 2011;
21:4409-15. [PMID:
21733692 DOI:
10.1016/j.bmcl.2011.06.045]
[Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2011] [Revised: 06/07/2011] [Accepted: 06/10/2011] [Indexed: 12/31/2022]
Abstract
A series of azepanone inhibitors of cathepsin S is described. Selectivity over both cathepsin K and cathepsin L was achieved by varying the P2 substituent. Ultimately, a balanced potency and selectivity profile was achieved in compound 39 possessing a 1-methylcyclohexyl alanine at P2 and nicotinamide as the P' substituent. The cellular potency of selected analogs is also described.
Collapse